Correlation Between AcelRx Pharmaceuticals and Nabriva Therapeutics

Can any of the company-specific risk be diversified away by investing in both AcelRx Pharmaceuticals and Nabriva Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AcelRx Pharmaceuticals and Nabriva Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between AcelRx Pharmaceuticals and Nabriva Therapeutics AG, you can compare the effects of market volatilities on AcelRx Pharmaceuticals and Nabriva Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AcelRx Pharmaceuticals with a short position of Nabriva Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of AcelRx Pharmaceuticals and Nabriva Therapeutics.

Diversification Opportunities for AcelRx Pharmaceuticals and Nabriva Therapeutics

0.0

Correlation Coefficient

AcelRx Pharmaceuticals  Nabriva Therapeutics

Pay attention - limited upside

The 3 months correlation between AcelRx and Nabriva is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding AcelRx Pharmaceuticals and Nabriva Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nabriva Therapeutics and AcelRx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AcelRx Pharmaceuticals are associated (or correlated) with Nabriva Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nabriva Therapeutics has no effect on the direction of AcelRx Pharmaceuticals i.e., AcelRx Pharmaceuticals and Nabriva Therapeutics go up and down completely randomly.

Pair Corralation between AcelRx Pharmaceuticals and Nabriva Therapeutics

If you would invest (100.00) in Nabriva Therapeutics AG on December 29, 2024 and sell it today you would earn a total of  100.00  from holding Nabriva Therapeutics AG or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

AcelRx Pharmaceuticals  vs.  Nabriva Therapeutics AG

AcelRx Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days AcelRx Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, AcelRx Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Nabriva Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Nabriva Therapeutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Nabriva Therapeutics is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with AcelRx Pharmaceuticals and Nabriva Therapeutics

The main advantage of trading using opposite AcelRx Pharmaceuticals and Nabriva Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AcelRx Pharmaceuticals position performs unexpectedly, Nabriva Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nabriva Therapeutics will offset losses from the drop in Nabriva Therapeutics' long position.

The idea behind AcelRx Pharmaceuticals and Nabriva Therapeutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.